Research and development in Parkinson's disease -
drugs in development.

Atuka continually reviews R&D activity where an indication of use in Parkinson's disease appears to be the intention of the company or institution. We focus on,

• Dopaminergic therapies in development
• Non-dopaminergic symptomatic therapies in development
• Anti-dyskinetic adjunctive therapies in development, and,
• Neuroprotective/ restorative therapies in development

We regularly publish summaries of our reviews, e.g.

Johnston TH, Brotchie JM. (2006) Drugs in development for Parkinson's disease: an update. Curr Opin Investig Drugs. 7(1):25-32.

Johnston TH, Fox SH, Brotchie JM. (2005) Advances in the delivery of treatments for Parkinson's disease. Expert Opin Drug Deliv. 2(6): 1059-73.

Johnston TH, Brotchie JM. (2004) Drugs in development for Parkinson's disease. Curr Opin Investig Drugs. 5(7):720-6.